Literature DB >> 5050732

Parathyroid function during chronic magnesium deficiency.

T B Connor, P Toskes, J Mahaffey, L G Martin, J B Williams, M Walser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5050732

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN： 0021-7263


× No keyword cloud information.
  12 in total

1.  Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.

Authors:  Charlotte Van Ende; Steven Van Laecke; Celine Marechal; Francis Verbeke; Nada Kanaan; Eric Goffin; Raymond Vanholder; Michel Jadoul
Journal:  J Nephrol       Date:  2014-05-10       Impact factor: 3.902

2.  Primary infantile hypomagnesaemia; report of two cases and review of literature.

Authors:  Y M Abdulrazzaq; F C Smigura; G Wettrell
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

3.  Generalized osteosclerosis in primary hyperparathyroidism.

Authors:  T B Connor; J Freijanes; R E Stoner; L G Martin; J Jowsey
Journal:  Trans Am Clin Climatol Assoc       Date:  1974

4.  Influence of magnesium on the secretion and action of parathyroid hormone.

Authors:  K S Nair; I M Holdaway; M C Evans; A D Cameron
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

5.  Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone.

Authors:  J J Freitag; K J Martin; M B Conrades; E Bellorin-Font; S Teitelbaum; S Klahr; E Slatopolsky
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

6.  Studies on mechanisms of hypocalcemia of magnesium depletion.

Authors:  C R Reddy; J W Coburn; D L Hartenbower; R M Friedler; A S Brickman; S G Massry; J Jowsey
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

7.  Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans.

Authors:  A Benjamin; A Moriakova; N Akhter; D Rao; H Xie; S Kukreja; E Barengolts
Journal:  Osteoporos Int       Date:  2009-03-12       Impact factor: 4.507

8.  Cis-platinum treatment for malignancy-associated humoral hypercalcemia in an athymic mouse model.

Authors:  L J Kukla; E C Abramson; W P McGuire; D H Shevrin; T Lad; S C Kukreja
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

9.  Hypocalcemia in patients with prostate cancer.

Authors:  S C Kukreja; A Shanmugam; T E Lad
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

10.  Inhibitory effects of hypermagnesemia on the renal action of parathyroid hormone.

Authors:  E Slatopolsky; A Mercado; A Morrison; J Yates; S Klahr
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.